The comments were made during her hearing with the House Oversight Committee.
At present, EpiPens have a shelf life of 18 months. The new formulation would boost time between refills to two years.
Ms. Bresch said Canonsburg, Pa.-based Mylan has been working on the reformulation for two years and hopes to submit it to the Food and Drug Administration within days.
More articles on supply chain:
Mylan CEO defends price hikes during heated EpiPen hearing: 5 takeaways
Self-directed robots are the new warehouse workers
Athenahealth CEO: EpiPen price hikes shouldn’t be a political issue
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
